Therapy News and Research

RSS

New study highlights need for equity in access to radiation therapy care in rural areas

The newest study of America's radiation oncology workforce finds that gender and race gaps have narrowed slightly, although persistent and growing geographic disparities point to a need for more equity in access to radiation therapy care.

5 Apr 2019

Newly developed melanin nanoparticles could slow tumor growth

The dark skin pigment melanin protects us from the sun's damaging rays by absorbing light energy and converting it to heat.

5 Apr 2019

FDA extends indication of metastatic breast cancer treatment to include male patients

The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.

5 Apr 2019

Expanding range and functionality of radiotracers for improved disease diagnosis

Biomedical imaging has revolutionized medicine, granting doctors a window into miniscule molecular and cellular processes inside the body. An EU-funded project helped to expand the view, developing innovative radiochemistry concepts and techniques that could lead to earlier diagnosis of diseases - saving lives.

4 Apr 2019

Researchers synthesize new polysulfide donor that has high anti-inflammatory effect

Researchers from Japan have developed a new polysulfide donor: a chemical compound composed of chains of sulfur atoms that can artificially increase reactive sulfur species (chemically reactive molecules containing sulfur) in cells and tissues.

4 Apr 2019

$Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy$

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

A currently approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in a clinical trial in Australia for medically refractory epilepsy.

4 Apr 2019

AACR Annual Meeting 2019 Highlighted Latest Advances in Cancer Research

On Friday, March 29 to Wednesday, April 3, the Georgia World Congress Center in Atlanta, Georgia, hosted the AACR Annual Meeting 2019.

From 10x Genomics, Inc. 4 Apr 2019

Study offers new hope for patients with decompensated cirrhosis

Decompensated cirrhosis is a chronic disease linked to numerous complications in its final stage. Professor Jonel Trebicka from Goethe University was involved in carrying out a pilot study demonstrating that the long-term administration of albumin in high doses stabilizes the circulatory function of these patients and protects them from sepsis.

4 Apr 2019

Ground-breaking research helps better understand the threat posed by antifungal drug resistance

Ground-breaking work by university experts in Tennessee, Texas and Swansea is helping develop a better understanding of the growing threat posed by antifungal drug resistance.

4 Apr 2019

Researchers unravel 3D structure of key molecular target for cancer treatment

Columbia University scientists, in collaboration with researchers from Nimbus Therapeutics, have demystified a metabolic enzyme that could be the next major molecular target in cancer treatment.

4 Apr 2019

UB researchers develop new method to more accurately predict tumor growth rates

University at Buffalo researchers have developed a new method to more accurately predict tumor growth rates, a crucial statistic used to schedule screenings and set dosing regimens in cancer treatment.

4 Apr 2019

Opioid epidemic fuels growing rates of some infectious diseases

The United States faces a converging public health crisis as the nation's opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

4 Apr 2019

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

4 Apr 2019

New immune-based therapy eliminates HPV in one-third of women with cervical precancerous lesions

A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial.

4 Apr 2019

Hepatitis C-infected thoracic organs can be safely transplanted, study finds

Infectious diseases experts and transplant physicians and surgeons at Brigham and Women's Hospital have blocked the transmission of hepatitis C from infected organ donors to recipients in need of hearts or lungs.

4 Apr 2019

New all-in-one immunotherapy approach kicks out hiding HIV and also kills it

In a first on the quest to cure HIV, University of Pittsburgh Graduate School of Public Health scientists report today in EBioMedicine that they've developed an all-in-one immunotherapy approach that not only kicks HIV out of hiding in the immune system, but also kills it.

4 Apr 2019

Study identifies possible way to predict which melanomas are hot and cold

Melanomas tend to be "hot" or "cold" - if they're hot, immunotherapy lights melanoma tumors like beacons for elimination by the immune system; but 40-50 percent of melanomas are cold, making them invisible to the immune system, and patients with cold tumors tend to show little benefit from immunotherapies.

4 Apr 2019

PET scans could be used to develop best practices for dementia

The application of positron emission tomography (PET) for amyloid plaques could aid clinical decision making for patients with dementia or mild cognitive impairment (MCI).

3 Apr 2019

UCR study: Surgery associated with higher survival of patients with HER2-positive stage 4 breast cancer

A student at the University of California, Riverside, presented research results at the annual meeting of the American Association for Cancer Research, or AACR, in Atlanta showing that surgery is associated with higher survival rates for patients with HER2-positive stage 4 breast cancer compared with those who did not undergo surgery.

3 Apr 2019

Salk researchers reveal new role for a driver of metastatic cancers

Metastatic ovarian, prostate and breast cancers are notoriously difficult to treat and often deadly. Now, Salk Institute researchers have revealed a new role for the CDK12 protein. The findings were published in the print version of Genes & Development on April 1, 2019.

3 Apr 2019

Therapy News and Research

New study highlights need for equity in access to radiation therapy care in rural areas

Newly developed melanin nanoparticles could slow tumor growth

FDA extends indication of metastatic breast cancer treatment to include male patients

Expanding range and functionality of radiotracers for improved disease diagnosis

Researchers synthesize new polysulfide donor that has high anti-inflammatory effect

Reformulated epileptic drug reaches first clinical trial for medically refractory epilepsy

AACR Annual Meeting 2019 Highlighted Latest Advances in Cancer Research

Study offers new hope for patients with decompensated cirrhosis

Ground-breaking research helps better understand the threat posed by antifungal drug resistance

Researchers unravel 3D structure of key molecular target for cancer treatment

UB researchers develop new method to more accurately predict tumor growth rates

Opioid epidemic fuels growing rates of some infectious diseases

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

New immune-based therapy eliminates HPV in one-third of women with cervical precancerous lesions

Hepatitis C-infected thoracic organs can be safely transplanted, study finds

New all-in-one immunotherapy approach kicks out hiding HIV and also kills it

Study identifies possible way to predict which melanomas are hot and cold

PET scans could be used to develop best practices for dementia

UCR study: Surgery associated with higher survival of patients with HER2-positive stage 4 breast cancer

Salk researchers reveal new role for a driver of metastatic cancers

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News